Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$5.17 +0.04 (+0.78%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Return on Sales [ROS] (2011 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Return on Sales [ROS] of -314.05% for Q2 2026, up 1102.17 percentage points from -1416.22% a year earlier and up 289.86 percentage points from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Return on Sales [ROS] (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Tonix Pharmaceuticals Holding was -568.43%, up 269.57 percentage points year-over-year; for FY2025, it was -959.05%, up 395.23 percentage points from FY2024.

  • In prior years, Tonix Pharmaceuticals Holding's Return on Sales [ROS] was -1354.28% in FY2024 (+169.66 pp) and -1523.94% in FY2023.
  • The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q3 2023.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +371.47 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 2085.41 percentage points; the weakest was Q3 2025, with a drop of 453.91 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -603.91% (Q1 2026), -895.84% (Q4 2025) and -1005.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Tonix Pharmaceuticals Holding 86.82 Mn -672.58 Mn 12.84 Mn -314.05%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -314.05%
Mar 31, 2026 -603.91%
Dec 31, 2025 -895.84%
Sep 30, 2025 -1,005.08%
Jun 30, 2025 -1,416.22%
Mar 31, 2025 -660.93%
Dec 31, 2024 -870.64%
Sep 30, 2024 -551.17%
Jun 30, 2024 -3,501.63%
Mar 31, 2024 -860.23%
Dec 31, 2023 -723.18%
Sep 30, 2023 -705.62%
Dec 31, 2015 -31,909.52%
Sep 30, 2015 -44,266.67%
Jun 30, 2015 -56,114.29%
Mar 31, 2015 -64,640.00%
Dec 31, 2014 -60,026.67%
Sep 30, 2014 -49,560.00%
Jun 30, 2014 -120,980.00%
Mar 31, 2014 -103,380.00%
API Access

Tonix Pharmaceuticals Holding Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEY